Description

Standard & Poor's Global Industry Surveys help meet the growing demand for in-depth industry analysis from a European, Asian and Latin American perspective. Designed for strategic planners, management consultants, money managers, researchers, business students, and academic faculty, Global Industry Surveys are an excellent way to get up to speed on current events, future trends and the competitive dynamics of leading industries outside of North America. Intended to complement a subscription to Standard & Poor's flagship industry research product - Industry Surveys - each Global Industry Survey will include the following sections: Current Environment, Industry Trends, How the Industry Operates, Key Industry Ratios and Statistics, Glossary, Industry References and Comparative Company Analysis.

Table of Contents

CURRENT ENVIRONMENT Government incentives, WTO drive growth of Asia's biotech industry China cracks down on drug safety Asian companies gear up for biosimilars opportunity Asia clashes over IP issues, compulsory licenses Peptech merges with Evogenix in Australia INDUSTRY PROFILE Biotech industry growing faster in Asia than in other parts of the world Japan slowly gains an edge in biotech Australia makes biotech a priority China invests in innovation India bets on research services, generic biologics, and ag-biotech Singapore, South Korea vie to be hubs INDUSTRY TRENDS Intellectual property protections are improving Growing technological capabilities Stem-cell research picks up in Asia where US left off Governments are advocates Asian venture capitalists emerge HOW THE INDUSTRY OPERATES Developing human biologics Financing a critical component for biotech Bringing a biologic to market Critical regulatory issues KEY INDUSTRY RATIOS AND STATISTICS GLOSSARY INDUSTRY REFERENCES COMPARATIVE COMPANY ANALYSIS